NMR studies on the molecular structure of azapropazone and interpretation of its pharmacokinetics and biotransformation
Fenner, H.; Mixich, G.
Arzneimittel-Forschung 23(5): 667-669
1973
ISSN/ISBN: 0004-4172 PMID: 4740209 Document Number: 58400
Document emailed within 1 workday
Related Documents
Faust-Tinnefeldt, G.F.; Geissler, H.E. 1978: Azapropazone and rheumatic combination therapy considering drug interactions: azapropazone aurothioglucose and azapropazone prednisolone Arzneimittel-Forschung 28(2): 337-341Gikalov, I.; Kaufmann, R.; Schuster, O. 1982: Human pharmacokinetics of different I.v. doses of azapropazone (HPLC-determination) Arzneimittel-Forschung 32(4): 423-426
Panchenko, E.P. 1998: Enoxaparin: molecular structure aspects, pharmacokinetics, efficiency in internal medicine Klinicheskaia Meditsina 76(11): 14-19
Taylor, J.A. 1974: Pharmacokinetics and biotransformation of chlorpropamide in the rat and dog Drug Metabolism and Disposition: the Biological Fate of Chemicals 2(3): 221-227
Wang, E.H.; Du, F.D.; Xiang, B.R. 1981: Molecular connectivity studies on quantitative structure-activity of drugs. II. Quantitative structure-activity relationships for leucomycins, lincomycins and clindamycins Yao Xue Xue Bao 16(2): 86-91
Kellner, H.M.; Eckert, H.G.; Fehlhaber, H.W.; Hornke, I.; Oekonomopulos, R. 1986: Pharmacokinetics and biotransformation following topical use of the local corticoid prednicarbate Zeitschrift für Hautkrankheiten 61(Suppl 1): 18-40
Kellner, H.M.; Arnold, C.; Christ, O.E.; Eckert, H.G.; Herok, J.; Hornke, I.; Rupp, W. 1981: Pharmacokinetics and biotransformation of the antimycotic drug ciclopiroxolamine in animals and man after topical and systemic administration Arzneimittel-Forschung 31(8a): 1337-1353
Hayashi, T.; Suzuki, K. 1993: Molecular biology of protein C-thrombomodulin pathway. Structure and function, and basic studies on its clinical application Nihon Rinsho. Japanese Journal of Clinical Medicine 51(6): 1610-1619
Heusse, D.; Marlard, M.; Bredenbac, J.; Decouvelaere, B.; Leroy, J.P.; Bieder, A.; Jumeau, H. 1985: Disposition of 14C-oltipraz in animals. Pharmacokinetics in mice, rats and monkeys. Comparison of the biotransformation in the infected mouse and in the schistosomes Arzneimittel-Forschung 35(9): 1431-1436
Mager, H.; Barth, A. 1979: Problems involved in the specification and interpretation of quantitative structure-activity relationships. Part 1: a modified type of structure-activity equations Die Pharmazie 34(9): 557-559
Tsapkina, E.N.; Gurskaia, G.V.; Zavgorodniĭ, S.G.; Lindeman, S.V.; Struchkov, I.T. 1988: The structure and antiviral activity of ribavirin analogs. II. Molecular and crystal structure of 1-(1,5-dihydroxy-3-oxapent-2-yl)-1,2,4-triazole-5-carboxamide Bioorganicheskaia Khimiia 14(8): 1092-1097
Moreno, G.; Gamba, G. 1996: Molecular biology in medicine. I. Molecular structure of the gene Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 48(1): 81-84
Scherling, D.; Karl, W.; Ahr, G.; Ahr, H.J.; Wehinger, E. 1988: Pharmacokinetics of nisoldipine. III. Biotransformation of nisoldipine in rat, dog, monkey, and man Arzneimittel-Forschung 38(8): 1105-1110
Hutschenreiter, J.; Scheuner, G. 1976: Submicroscopic structure of collagen--a basis for the interpretation of corresponding polarization-optical and histochemical findings Zeitschrift für Mikroskopisch-Anatomische Forschung 90(6): 969-988
Ianelli, S.; Pelizzi, G. 1992: Structural studies on H2-antagonists: crystal and molecular structure of N-cyano-N'-methyl-N"-(2-[(2-amino-5-thiazolyl)methylthio]ethyl) guanidine and N-cyano-3-[(2-guanidino-5-thiazolyl)methylthio]propionamidine Farmaco 47(5): 607-621
Lutz, F. 1988: The connections between structure, pharmacokinetics and effects of glucocorticoids Tierarztliche Praxis 16(4): 333-341
Fernández-Metzler, C.L.; Owens, K.G.; Baillie, T.A.; King, R.C. 1999: Rapid liquid chromatography with tandem mass spectrometry-based screening procedures for studies on the biotransformation of drug candidates Drug Metabolism and Disposition: the Biological Fate of Chemicals 27(1): 32-40
Mishler, J.M. 1980: Pharmacokinetics of middle-molecular hydroxyethyl starch (HAS 200/0,5 Infusionstherapie und Klinische Ernahrung 7(2): 96-102
Matsumoto, F.; Nishiwaki, K.; Morita, M. 1991: Chemical structure , anti-bacterial activity and pharmacokinetics of new quinolones Nihon Rinsho. Japanese Journal of Clinical Medicine 49(10): 2291-2298
Flahault, A. 2013: Interpretation of epidemiologic studies La Revue du Praticien 63(8): 1153-1158